Taking a GLP-1 receptor agonist was associated with a lower risk for cirrhosis and related complications in patients with ...

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.

THE RISING global prevalence of youth-onset Type 2 diabetes (Y-T2D) is a serious public health concern. With an aggressive ...

The main findings of the paper revealed that Black patients were underrepresented in clinical trials, particularly with ...

Researchers studying python intestinal regeneration found pathways similar to humans, offering insights into treating ...

Men who followed the plan were able to stop injecting themselves with insulin within a month of starting their fasting ...

Sign up to our free email newsletter for daily roundups of the biggest headlines as well as all the latest breaking news ...

People with type 2 diabetes are at a high risk of developing severe health complications such as heart attacks, strokes, heart failure, and advanced kidney disease. However, recent research from ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Share on PinterestMore evidence suggests that semaglutide drugs could help lower the risk of Alzheimer’s disease. Image ...

The Lagos State Government has launched a state-wide screening and public enlightenment campaign on hypertension and diabetes.

Could the expectation that men need to be "manly" end up damaging their hearts? Researchers reveal a concerning trend among ...